Home › Nausea and Vomiting › NCT07378839
Alternate Nostril Breathing (ANB) for 1st Trimester Nausea and Vomiting
Recruiting
Who can join
Ages 18 and older · Women
Full eligibility criteria
Inclusion Criteria: * Pregnant individuals aged 18 years or older * Viable pregnancy with a gestational age between 6 0/7 - 12 6/7 weeks of gestation, confirmed by last menstrual period or ultrasound * Diagnosed with mild to moderate NVP (PUQE-24 score between 4-12) * Ability to understand and read English Exclusion Criteria: * Severe nausea and vomiting, defined as a PUQE score \>12, or diagnosis of hyperemesis gravidarum requiring hospitalization or intravenous fluid therapy * Pre-existing, active or acute respiratory conditions (e.g., asthma, COPD) * History of severe anxiety disorders affecting breathing patterns * Known deviated nasal septum * Nausea and vomiting that pre-dates the pregnancy or is suspected to be due to a etiology other than pregnancy
About the study
This is a prospective, two-arm, non-blinded randomized controlled study designed to evaluate the effects of a one-week alternate nostril breathing (ANB) intervention on nausea and vomiting severity in pregnant individuals during their first trimester.
What is being tested
- Alternate Nostril Breathing (behavioral)
Sponsor: University of Minnesota · Participants: 100 · Started: Feb 10, 2026
Contact the study team
- Erin Wesley · Phone: 612-624-9208
Official record on ClinicalTrials.gov — NCT07378839
Locations in the U.S.
| Minnesota | University of Minnesota, Minneapolis |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.